TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CRBP

Corbus Pharmaceuticals Holding

Healthcare · Biotechnology

7.30$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

Corbus Pharmaceuticals Holding (CRBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -64 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CRBP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2.4 -4.6 -14 -28 -30 -46 -100 -48 -38 -36,100 -42 -64
0.0 0.0 0.1 0.3 0.5 1.2 1.7 1.6 1.5 641 -2.7 -1.1
0.2 1.2 3.2 5.7 7.6 12 12 9.5 5.7 3,470 6.1 6.3
0.1 1.2 3.2 5.7 7.7 12 13 11 6.6
0.1 3.0 3.1 -2.2 17 12 -3.2 -16 -4.0 3,066 -5.6 9.1
0.1 0.1 0.4 0.7 2.3 2.7 0.5 0.1 0.0 0.0 0.0 0.0
-0.1 -0.1 -0.4 -0.7 -2.3 -2.7 -0.5 -73 30 35,642 -121 -1.6
0.0 0.0 0.0 0.0
10 11 17 79 12 41 142
-1.9 -0.5 0.0 -2.9 -0.6 -3.2 19 0.1 -0.5 -2.9 -15 0.0
8.4 11 17 76 11 38 155 61 -0.5 -2,821 167 77
6.0 6.1 2.8 48 -21 -10.0 54 -61 -8.0 -3,279 3.5 11
-2.4 -4.8 -14 -29 -32 -48 -100 -48 -38 -36,100 -42 -64

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?